This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Myeloid leukaemia
CD2_MYELOID_LEUKAEMIA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
922 |
4. Check minimum number of eventsNone |
922 |
5. Include endpointsNone |
922 |
6. Filter based on genotype QC (FinnGen only) |
922 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemia myeloides
Similar endpoints
↥List of similar endpoints to
Myeloid leukaemia
based on the number of shared cases.
Similar with more cases:
- Myeloid leukaemia
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 922 | 405 | 517 |
| Unadjusted period prevalence (%) | 0.19 | 0.14 | 0.23 |
| Median age at first event (years) | 63.95 | 58.58 | 68.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 912
- Matched controls
- 9119
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
323.0
567
*
XW000
NOMESCO Finland
Bone marrow biopsy
71.8
323.0
518
164
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
168.7
323.0
696
171
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
323.0
304
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
300.1
271
*
189
Kela drug reimbursment
Imatinib
388.1
190.0
185
6
WW500
NOMESCO Finland
Blood transfusion
23.6
179.5
266
156
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
31.8
168.6
227
94
L01XE01
ATC
[U] imatinib; oral
320.3
161.2
159
6
127
Kela drug reimbursment
Transplant complication
47.3
134.3
164
42
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
133.7
125
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
165.1
123.8
128
9
M04AA01
ATC
allopurinol; systemic
6.7
118.8
362
810
L01XX05
ATC
hydroxycarbamide; oral
49.5
114.9
139
33
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
420.8
114.2
112
*
A05AA02
ATC
ursodeoxycholic acid; oral
35.7
111.6
145
48
L03AA02
ATC
filgrastim; parenteral
19.7
110.6
172
106
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
343.2
92.7
92
*
R50.9
ICD-10 Finland
Fever, unspecified
5.7
90.6
306
737
A04AA01
ATC
ondansetron; systemic, rectal
8.8
88.6
206
293
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
85.4
297
733
316
Kela drug reimbursment
Imatinib
300.7
82.0
82
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.7
79.5
263
605
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
46.0
77.5
95
23
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.9
75.2
185
283
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
123.4
74.2
79
7
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
204.0
73.3
75
*
J05AB11
ATC
valaciclovir; oral
5.2
71.7
256
634
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
69.7
174
270
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.5
68.3
127
116
L01BB02
ATC
mercaptopurine; oral
50.8
65.8
79
17
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
66.9
64.5
74
12
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.6
64.4
148
200
152
Kela drug reimbursment
Nilotinib
+∞
64.3
61
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
60.1
57
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
616.4
59.4
58
*
J01MA12
ATC
levofloxacin; systemic
3.8
57.4
306
1081
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
20.9
56.0
84
44
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
43.8
55.9
69
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.0
55.0
122
154
D70.89
ICD-10 Finland
Neutropenic splenomegaly
28.2
53.4
73
28
D64.9
ICD-10 Finland
Anaemia, unspecified
4.6
52.7
207
548
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
537.2
52.0
51
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
537.2
52.0
51
*
150
Kela drug reimbursment
Dasatinib
+∞
51.5
49
*
J02AC03
ATC
voriconazole; systemic
62.9
51.0
59
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
50.5
530
2962
WW200
NOMESCO Finland
Immunization
10.8
50.3
100
103
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
19.0
49.8
77
44
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
49.4
47
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.0
48.8
74
40
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.3
48.6
76
45
L01XX28
ATC
[D] imatinib; oral
+∞
48.4
46
*
L04AD01
ATC
ciclosporin; systemic
13.3
48.1
86
71
L01XE06
ATC
[U] dasatinib; systemic
+∞
46.2
44
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
129.3
46.2
49
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
23.2
45.1
65
30
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.2
44.2
79
65
L01XE08
ATC
[U] nilotinib; oral
+∞
43.1
41
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.6
41.1
111
187
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
29.2
40.8
55
20
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.7
40.5
123
241
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
39.6
230
834
ZX120
NOMESCO Finland
Intravenous
4.0
39.3
176
516
J01MA14
ATC
moxifloxacin; systemic
4.4
37.6
150
394
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
43.0
36.5
45
11
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
35.7
34
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
34.6
33
*
212
Kela drug reimbursment
Gout
8.1
34.0
79
106
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
33.5
317
1548
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
33.5
32
*
328
Kela drug reimbursment
Nilotinib
+∞
33.5
32
*
B73
ICPC
Leukaemia
93.6
33.0
36
*
J02AC04
ATC
posaconazole; systemic
+∞
32.5
31
*
L01EA03
ATC
nilotinib; oral
+∞
32.5
31
*
L04AA06
ATC
mycophenolic acid; systemic
11.4
32.2
61
57
ZX112
NOMESCO Finland
Subcutaneous
8.6
31.1
69
86
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.8
30.6
91
172
TGC00
NOMESCO Finland
Bronchial lavation
7.8
30.5
72
99
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
39.6
30.5
38
10
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
33.0
29.3
38
12
L04AA01
ATC
[U] ciclosporin; systemic
11.0
29.1
56
54
N02AA05
ATC
oxycodone; systemic
2.9
28.4
204
835
324
Kela drug reimbursment
Dasatinib
+∞
28.3
27
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.4
27.9
87
174
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
6.8
27.7
72
114
1DB06
NOMESCO Finland
NA
+∞
27.2
26
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
64.1
27.1
31
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
26.9
71
115
WW409
NOMESCO Finland
Other aferesis
99.8
26.8
29
*
Z51.5
ICD-10 Finland
Palliative care
4.1
26.7
109
289
J05AB01
ATC
aciclovir; systemic
2.5
26.2
244
1153
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
26.2
25
*
H02AB09
ATC
hydrocortisone; systemic
7.9
25.5
59
79
J02AC01
ATC
fluconazole; systemic
2.2
25.5
360
2089
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
25.1
129
415
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
40.1
25.0
31
8
C90.0
ICD-10 Finland
Multiple myeloma
11.8
24.9
46
41
H02AB04
ATC
methylprednisolone; systemic
2.8
24.9
182
748
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.3
24.4
77
156
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
24.2
250
1242
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
26.3
24.1
33
13
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
235.6
22.7
23
*
2AX04
NOMESCO Finland
NA
123.1
22.7
24
*
JN4BD
NOMESCO Finland
Extensive body CT
2.9
22.2
153
601
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
22.0
21
*
1BC07
NOMESCO Finland
NA
+∞
22.0
21
*
L01EA02
ATC
dasatinib; oral
+∞
22.0
21
*
TPH00
NOMESCO Finland
Phlebotomy
27.2
21.4
29
11
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
21.1
334
1990
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
20.9
20
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
27.8
20.1
27
10
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
75.2
19.8
22
*
L03AB05
ATC
interferon alfa-2b; parenteral
25.2
19.6
27
11
A40.8
ICD-10 Finland
Other streptococcal sepsis
15.2
19.0
31
21
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
18.8
18
*
H02AB06
ATC
prednisolone; systemic
1.9
18.4
445
3071
A41.8
ICD-10 Finland
Other specified sepsis
7.6
18.4
43
59
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
45.0
18.3
22
5
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
18.1
135
554
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
53.6
18.0
21
*
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.8
17
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
17.8
17
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
17.6
196
988
TAB00
NOMESCO Finland
Lumbar puncture
4.3
17.6
66
161
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.8
17.5
35
37
306
Kela drug reimbursment
Erythropoietin and darbepoetin
24.6
17.4
24
10
ZX121
NOMESCO Finland
Central venous catheter
26.2
17.0
23
9
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
26.2
17.0
23
9
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
16.7
16
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
+∞
16.7
16
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
91.8
16.6
18
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
13.9
16.1
27
20
A07AA02
ATC
nystatin; oral
3.1
16.0
91
314
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.0
15.9
51
106
5BA08
NOMESCO Finland
NA
17.6
15.7
24
14
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
15.7
15
*
170
Kela drug reimbursment
Bosutinib
+∞
15.7
15
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
86.6
15.6
17
*
B03XA01
ATC
erythropoietin; parenteral
11.5
15.3
28
25
ZX108
NOMESCO Finland
Inhalation
11.5
15.3
28
25
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
15.1
218
1221
B03XA02
ATC
darbepoetin alfa; parenteral
5.9
15.1
42
74
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.1
15.0
31
35
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
14.6
14
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
27.7
14.3
19
7
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
27.7
14.3
19
7
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
8.2
14.1
31
39
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.7
14.0
40
73
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
13.9
93
357
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
13.8
118
520
SPAT1088
SPAT
Blood transfusion
20.4
13.8
20
10
C03CA01
ATC
furosemide; systemic
1.8
13.7
316
2082
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.3
13.6
32
45
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
13.6
13
*
1DB07
NOMESCO Finland
NA
+∞
13.6
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.9
13.4
37
65
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
13.3
203
1159
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
13.1
56
155
JN4AD
NOMESCO Finland
Body CT examination
2.6
12.8
96
391
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
9.9
12.8
25
26
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
12.5
12
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
12.5
12
*
D45
ICD-10 Finland
Polycythaemia vera
8.8
12.1
25
29
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.9
347
2432
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.8
11.8
29
44
B02.9
ICD-10 Finland
Zoster without complication
3.0
11.7
67
232
F43.29
ICD-10 Finland
Adaptation disorder UNS
8.3
11.6
25
31
L03AA13
ATC
pegfilgrastim; parenteral
3.7
11.5
49
136
L01XE14
ATC
[U] bosutinib; oral
+∞
11.5
11
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
11.5
11
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.1
11.4
62
209
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
35.5
11.3
14
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
11.2
109
513
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
20.3
11.2
16
8
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.0
11.1
44
115
A98
ICPC
Health maint/preventive medicine
0.6
11.1
675
7611
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
43.9
10.9
13
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
43.9
10.9
13
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
12.1
10.9
19
16
D75.2
ICD-10 Finland
Essential thrombocytosis
10.7
10.8
20
19
JN6AD
NOMESCO Finland
CT of torso and neck
8.1
10.6
23
29
RS220
NOMESCO Finland
NA
7.1
10.6
25
36
360
Kela drug reimbursment
Bosutinib
+∞
10.4
10
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
10.3
95
432
L03AA04
ATC
NA
32.9
10.3
13
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
19.0
10.3
15
8
6BA02
NOMESCO Finland
NA
23.7
10.3
14
6
A02BC02
ATC
pantoprazole; systemic
1.6
10.2
561
4574
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
10.2
87
384
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
10.0
93
428
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
10.0
44
127
J01FF01
ATC
clindamycin; systemic
1.7
9.9
234
1528
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
26.3
9.8
13
5
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
26.3
9.8
13
5
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.8
171
1013
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
9.8
61
225
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
55.6
9.7
11
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
9.7
51
169
D64.8
ICD-10 Finland
Other specified anaemias
4.9
9.5
30
63
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
101.0
9.4
10
*
B74
ICPC
Malignant neoplasm blood other
101.0
9.4
10
*
A02BC01
ATC
omeprazole; systemic
1.7
9.4
255
1728
J01MA02
ATC
ciprofloxacin; systemic
1.6
9.4
349
2569
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
9.4
9
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
9.4
9
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
2AX05
NOMESCO Finland
NA
+∞
9.4
9
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
9.4
9
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.3
9.3
84
380
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.4
9.2
77
334
A01AB04
ATC
amphotericin B; local oral
2.7
9.1
63
248
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.6
255
1761
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
8.6
277
1958
E89.4
ICD-10 Finland
Postprocedural ovarian failure
90.9
8.4
9
*
L03AA10
ATC
lenograstim; parenteral
+∞
8.3
8
*
C92
ICD-10 Finland
Myeloid leukaemia
+∞
8.3
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.3
8
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
8.3
8
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
10.9
8.3
15
14
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
8.2
41
132
L01AA01
ATC
cyclophosphamide; systemic
17.3
8.1
12
7
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
22.2
8.0
11
5
H26.3
ICD-10 Finland
Drug-induced cataract
10.9
7.8
14
13
ED1AA
NOMESCO Finland
Mandipular X-ray examination
9.5
7.8
15
16
H02AB02
ATC
dexamethasone; systemic
2.0
7.8
96
502
RS221
NOMESCO Finland
NA
5.3
7.7
22
42
R4110
NOMESCO Finland
Physiotherapy
1.6
7.6
228
1575
K12.10
ICD-10 Finland
Stomatitis NOS
18.5
7.6
11
6
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
25.2
7.6
10
*
B37.7
ICD-10 Finland
Candidal sepsis
25.2
7.6
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.2
7.6
19
31
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.6
404
3186
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
7.5
29
76
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.1
7.4
22
44
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
7.4
37
119
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.5
7.4
18
28
B59
ICD-10 Finland
Pneumocystosis
80.7
7.4
8
*
1BC01
NOMESCO Finland
NA
80.7
7.4
8
*
373
Kela drug reimbursment
Ponatinib
+∞
7.3
7
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
7.4
7.2
16
22
M87.3
ICD-10 Finland
Other secondary osteonecrosis
30.3
7.2
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
8.0
7.1
15
19
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
7.6
6.9
15
20
1CX01
NOMESCO Finland
NA
13.9
6.9
11
8
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.9
6.9
21
44
SPAT1074
SPAT
Venesection
9.4
6.8
13
14
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.2
6.8
33
105
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.8
154
984
C91.7
ICD-10 Finland
Other lymphoid leukaemia
40.4
6.8
8
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.7
6.7
27
74
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
6.7
97
537
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
6.6
58
261
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
8.8
6.6
13
15
A07AA09
ATC
vancomycin; oral
4.5
6.5
21
47
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
6.5
84
445
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
70.3
6.4
7
*
V03AC03
ATC
deferasirox; oral
70.3
6.4
7
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.6
6.3
15
23
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
6.3
6
*
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
+∞
6.3
6
*
L01XE24
ATC
[U] ponatinib; oral
+∞
6.3
6
*
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
J05AX18
ATC
letermovir; oral
+∞
6.3
6
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
6.3
6
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.2
88
483
B02AA02
ATC
tranexamic acid; systemic
1.8
6.2
109
643
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
8.7
6.1
12
14
WW300
NOMESCO Finland
Transfer of autologic stem cells
10.1
6.0
11
11
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.0
176
1203
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
538
876
13.35
307.65
18.6
4.0
u/l
299.9
252.0
2.08
528
821
(3042111) Morphology [Interpretation] in Bone marrow Narrative
304
132
33.87
307.65
5.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
283
75
54.00
307.65
1.4
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
190
62
38.34
298.40
1.4
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
191
66
36.24
294.68
2.8
2.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
197
126
19.61
236.33
1.5
1.4
u/ml
109.6
104.7
0.24
55
24
(3023520) Reticulocytes [#/volume] in Blood
391
684
9.19
235.96
7.4
2.5
e9/l
65.3
69.5
0.97
313
544
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
201
142
17.82
228.91
1.4
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
446
934
8.31
227.34
7.6
2.6
%
1.8
1.8
0.24
429
841
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
199
144
17.35
223.56
11.6
6.6
iu/ml
370.7
512.7
0.25
39
19
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
196
142
17.26
219.93
1.4
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
181
119
18.68
213.49
4.1
3.8
u/ml
538.1
2409.3
0.52
15
12
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
216
200
13.80
209.52
4.3
2.9
g/l
3.7
3.7
0.11
209
190
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
183
134
16.79
203.66
1.4
1.3
u/ml
253.2
248.3
0.05
116
76
(3048929) Epstein Barr virus Ab [Presence] in Serum
209
203
13.02
196.06
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
338
607
8.21
195.65
11.7
4.2
%
1.7
0.9
3.96
206
187
(3005719) IgG [Mass/volume] in Serum or Plasma
312
523
8.51
191.89
3.1
2.9
g/l
9.5
10.9
4.86
299
480
(3024471) HLA-A [Type]
104
17
68.83
189.61
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
102
16
71.56
187.20
1.5
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
147
88
19.68
180.79
1.7
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
157
113
16.54
175.63
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
189
187
12.46
174.37
4.1
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
191
192
12.29
174.35
3.8
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
409
1012
6.47
169.31
13.5
5.9
mmol/l
1.0
1.0
0.23
404
922
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
161
6
324.49
163.33
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
87
15
63.94
156.72
4.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
289
549
7.21
155.60
11.7
4.0
%
1.0
0.4
4.63
139
136
(3028026) IgM [Mass/volume] in Serum or Plasma
256
430
7.86
154.76
1.6
1.7
g/l
1.2
1.5
0.87
244
395
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
154
139
13.10
150.14
4.2
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
84
17
54.26
146.64
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
419
1207
5.53
142.51
11.4
3.5
mmol/l
0.8
0.8
0.26
406
1126
(3004809) Band form neutrophils/100 leukocytes in Blood
138
115
13.94
141.14
10.3
3.8
%
1.3
1.2
0.05
116
97
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
174
207
10.13
139.67
1.7
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
79
15
57.51
139.57
1.3
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
85
23
40.61
138.65
5.4
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
277
577
6.43
134.35
12.7
4.3
%
0.5
0.2
0.92
195
173
(3016650) Hepatitis A virus Ab [Presence] in Serum
134
119
13.01
131.54
1.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
243
454
6.91
131.38
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
260
542
6.29
125.33
12.4
4.3
%
5.0
0.7
2.78
152
145
(44806118)
110
86
14.39
116.36
2.2
1.6
—
—
—
0
0
(44790048)
110
86
14.39
116.36
2.2
1.6
—
—
—
0
0
(44790047)
110
86
14.39
116.36
2.2
1.6
—
—
—
0
0
(44790049)
110
86
14.39
116.36
2.2
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
105
76
15.46
116.04
4.8
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
201
353
7.00
114.54
1.9
2.0
g/l
1.4
1.6
0.95
177
311
(3008757) Leukocyte morphology finding [Identifier] in Blood
108
89
13.61
110.62
11.4
4.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
117
111
11.93
109.58
8.9
6.2
mg/l
10.2
11.8
2.48
112
102
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
105
84
13.98
109.46
4.9
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
491
1937
4.28
104.98
9.2
2.8
umol/l
325.2
8054.8
8.35
469
1663
(42870588) Differential panel, method unspecified - Blood
558
2418
4.31
104.33
24.8
5.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
86
52
18.14
104.17
1.8
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
65
19
36.73
103.42
1.7
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
59
13
48.42
100.64
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
276
732
4.95
99.27
1.7
1.6
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
92
0
+∞
97.67
15.3
0.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
79
47
18.29
96.33
3.9
1.8
%
25.7
33.2
—
20
6
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
79
47
18.29
96.33
5.6
1.9
e6/l
413.2
713.4
1.29
43
19
(3017354) Segmented neutrophils/100 leukocytes in Blood
90
69
14.35
95.97
10.5
3.4
%
45.5
54.0
1.30
64
52
(40765096) Chromosome analysis panel by Banding
66
27
26.25
94.20
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
291
841
4.59
93.35
1.7
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
115
141
9.18
89.03
1.9
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
249
661
4.79
88.57
2.3
3.0
g/l
65.4
66.3
1.15
241
600
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
85
72
12.90
85.23
5.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
85
72
12.90
85.23
5.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
85
72
12.90
85.23
5.4
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
626
3255
3.88
82.93
23.3
5.9
%
0.7
0.7
1.04
611
3040
(3019069) Monocytes/100 leukocytes in Blood
638
3364
3.91
82.61
25.6
6.2
%
10.0
8.8
4.56
622
3146
(3006504) Eosinophils/100 leukocytes in Blood
635
3349
3.88
81.93
24.0
5.9
%
2.4
2.8
6.40
621
3118
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
99
112
9.78
81.39
2.1
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
89
89
10.96
79.96
2.4
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
641
3436
3.84
79.86
24.5
6.0
%
31.6
27.1
12.96
624
3199
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
61
31
21.00
79.72
6.6
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
61
31
21.00
79.72
6.6
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
78
64
13.22
79.67
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
61
32
20.34
78.61
6.6
1.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
333
1192
3.81
77.59
5.0
2.1
s
29.1
29.8
1.59
324
1149
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
68
46
15.88
77.47
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
84
81
11.31
77.33
4.1
2.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
70
52
14.49
75.74
6.4
2.0
e9/l
1.2
1.1
0.23
31
28
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
65
45
15.46
73.08
6.8
4.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
617
3385
3.49
70.59
21.9
5.7
%
49.8
57.8
30.95
599
3168
(46235355) HIV 1 and 2 tests - Meaningful Use set
289
1015
3.69
68.13
1.8
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
204
562
4.38
67.83
3.5
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
70
65
11.57
65.94
1.6
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
639
3675
3.41
65.64
24.5
6.0
e9/l
0.2
0.2
5.52
590
3245
(3001604) Monocytes [#/volume] in Blood
623
3547
3.33
64.73
21.2
5.7
e9/l
0.6
0.6
0.24
577
3069
(3006315) Basophils [#/volume] in Blood
624
3558
3.33
64.63
21.2
5.7
e9/l
0.0
0.0
2.44
578
3088
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
110
8.52
63.95
1.8
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
626
3636
3.25
61.58
21.6
5.8
e9/l
1.9
1.9
0.06
585
3207
(3020779) Urea [Moles/volume] in Serum or Plasma
221
689
3.90
61.53
9.2
7.6
mmol/l
8.4
10.3
3.87
215
652
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
327
1317
3.30
61.11
4.4
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
43
19
23.69
59.26
8.7
1.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
92
144
6.99
57.23
1.3
1.2
u/l
151.9
32.2
2.89
82
128
(3013650) Neutrophils [#/volume] in Blood by Automated count
670
4147
3.25
57.02
42.7
9.0
e9/l
3.5
4.2
2.73
630
3647
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
53
41
13.65
55.81
1.5
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
53
41
13.65
55.81
1.5
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
444
2228
2.92
55.02
16.1
4.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
67
76
9.43
54.64
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
344
1510
3.04
54.38
17.7
4.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
84
126
7.23
54.30
2.1
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
55
48
12.12
53.80
2.1
2.5
%
38.2
39.3
0.06
16
12
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
79
114
7.49
52.85
2.0
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
39
19
21.39
51.59
1.8
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
48
36
14.01
51.40
3.7
1.9
%
17.8
16.2
0.12
19
13
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
628
3878
2.94
51.08
26.1
6.4
umol/l
11.5
11.6
0.11
612
3677
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
75
108
7.47
50.23
5.0
1.6
pg
34.0
32.4
1.88
75
108
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
120
273
4.90
50.09
3.3
2.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
177
541
3.81
50.00
1.9
2.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
110
237
5.13
48.92
2.4
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
303
1306
2.97
48.64
1.6
1.5
g/l
2.2
2.5
3.11
261
799
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
45
36
13.09
46.35
2.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
45
36
13.09
46.35
2.8
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
335
1557
2.81
46.34
3.2
1.7
mg/l
3.2
1.2
3.82
290
1211
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
31
11
29.13
45.98
1.3
4.0
—
—
—
0
0
(3036489) Thrombin time
109
246
4.89
45.82
4.2
2.4
s
21.7
21.6
0.10
103
221
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
49
47
10.95
44.96
2.6
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
93
189
5.36
44.09
1.6
2.1
mg/l
26.7
12.3
1.42
81
171
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
236
934
3.05
43.58
3.0
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
48
47
10.72
43.41
2.7
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
236
936
3.04
43.40
2.9
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
593
3742
2.64
42.91
20.4
7.1
mmol/l
1.2
1.2
0.87
513
3141
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
222
860
3.08
42.46
14.1
2.8
umol/l
7.9
9.0
0.36
214
760
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
28
10
28.85
41.36
1.4
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
124
341
4.05
40.30
2.9
1.9
ug/l
6.4
2.3
0.59
118
300
(21494814) CD8 cells/100 lymphocytes in Specimen
33
21
16.26
38.46
4.3
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
546
3425
2.46
38.23
17.4
6.2
mmol/l
1.2
1.2
1.43
521
3078
(3037692) Legionella sp identified in Specimen by Organism specific culture
39
34
11.93
38.02
1.2
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
41
40
10.68
37.11
1.5
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
73
139
5.62
37.07
8.1
3.6
%
48.9
59.1
5.86
73
139
(3013727) Leukocytes other/100 leukocytes in Blood
35
28
12.95
35.95
8.4
5.3
%
41.2
50.7
0.87
35
28
(3044640) Blood type and Crossmatch panel - Blood
414
2363
2.36
34.99
13.2
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
25
13.22
33.29
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
393
2229
2.33
33.29
15.4
4.0
ph
7.4
7.4
0.63
77
422
(3001964) Herpes simplex virus Ag [Presence] in Specimen
28
18
16.01
32.38
1.8
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
37
6
64.13
32.27
3.7
2.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
35
34
10.66
31.72
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
45
61
7.70
31.62
1.2
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
511
3284
2.25
31.48
15.2
4.9
g/l
33.9
35.1
4.98
498
3053
(3022948) Iron [Moles/volume] in Serum or Plasma
253
1209
2.51
31.20
2.4
2.5
umol/l
15.5
12.7
5.76
244
1124
(3014148) Varicella zoster virus Ab [Titer] in Serum
43
57
7.86
30.79
1.3
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
337
1841
2.31
30.64
10.7
4.0
%
85.2
87.8
1.08
327
1797
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
228
1049
2.56
30.38
2.5
2.6
%
30.3
22.4
6.92
188
897
(3004789) Transferrin [Mass/volume] in Serum or Plasma
236
1113
2.51
29.78
2.4
2.5
g/l
2.2
2.3
4.67
225
1040
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
324
1768
2.28
29.28
12.3
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
511
3401
2.13
27.37
19.0
4.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
73
184
4.22
26.46
2.9
4.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
24
18
13.66
25.46
1.5
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
86
251
3.68
25.40
2.7
3.9
mg/l
44.7
83.2
0.80
74
204
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
85
247
3.69
25.27
2.2
3.9
ratio
42.6
1.9
—
5
22
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
31
35
9.13
25.18
2.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
50
96
5.45
25.09
5.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
32
39
8.46
24.50
1.5
5.6
—
34.5
—
0
10
(3005988) Vibrio sp identified in Specimen by Organism specific culture
50
99
5.28
24.25
5.0
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
458
3020
2.03
24.08
4.3
2.8
ug/l
532.7
142.9
8.19
439
2752
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
84
251
3.58
23.94
2.8
3.9
mg/l
26.3
35.5
1.59
72
207
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
24
20
12.29
23.92
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
96
317
3.26
23.38
6.8
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
183
876
2.36
21.69
3.4
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
285
3.27
21.44
1.8
2.7
g/l
9.8
10.5
0.64
72
243
(3042936) Bacteria identified in Isolate by Culture
215
1118
2.20
20.84
2.2
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
63
170
3.90
20.79
4.3
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
29
39
7.64
20.45
2.0
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
306
3.11
20.22
1.8
2.6
g/l
3.6
3.7
0.36
64
219
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
307
3.10
20.11
1.8
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
307
3.10
20.11
1.8
2.6
g/l
7.0
7.4
0.81
64
227
(3013826) Glucose [Moles/volume] in Serum or Plasma
585
4383
1.92
19.37
12.4
5.0
mmol/l
6.8
6.7
0.22
570
4110
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
85
292
3.11
19.33
2.9
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
319
1970
1.95
19.13
2.5
2.2
mg/l
3.0
3.1
0.26
274
1661
(3007853) Bacteria identified in Skin by Aerobe culture
178
886
2.25
19.06
1.9
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
62
177
3.68
18.87
1.7
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
22
24
9.37
18.26
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
360
2346
1.88
18.11
6.3
3.3
u/l
34.2
33.2
0.13
348
2235
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
116
487
2.58
18.11
2.9
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
285
3.02
17.66
1.9
2.7
g/l
3.2
3.1
0.21
64
223
(3044290) Cell count panel - Cerebral spinal fluid
48
120
4.16
17.56
3.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
61
181
3.54
17.53
2.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
296
1834
1.90
17.24
2.2
1.4
—
—
—
0
0
(4035726)
135
631
2.33
16.64
1.7
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
23
30
7.84
16.61
1.0
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
351
2322
1.83
16.45
3.8
2.6
u/l
51.3
57.8
3.10
330
2142
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
48
126
3.96
16.45
2.6
2.1
u/l
22463.6
2696.0
0.77
15
42
(40758558) Short blood count panel - Blood
287
1798
1.87
15.93
30.5
6.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
442
3164
1.76
15.63
34.1
9.7
e9/l
0.1
0.0
0.87
388
2601
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
108
478
2.43
15.00
1.6
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
392
2737
1.75
14.92
4.7
3.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
32
66
4.99
14.82
2.5
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
444
3220
1.73
14.69
10.5
10.5
inr
1.2
1.3
0.62
123
894
(3016018) Differential panel - Cerebral spinal fluid
29
56
5.31
14.45
2.7
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
13
11.71
14.45
1.3
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
58
191
3.17
14.14
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
51
155
3.42
14.14
1.4
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
16
16
10.16
14.05
1.1
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
49
146
3.49
14.00
3.1
1.3
e6/l
42.5
968.9
0.67
41
119
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
49
146
3.49
14.00
3.1
1.2
e6/l
8.3
10.6
0.11
39
116
(3019309) Folate [Moles/volume] in Red Blood Cells
248
1544
1.83
13.73
1.9
1.8
nmol/l
1242.2
1185.5
0.41
220
1153
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
50
156
3.33
13.31
1.2
1.3
miu/ml
269.9
243.0
0.12
11
72
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
37
6.07
12.63
3.0
2.4
u/ml
997.2
993.1
0.01
22
37
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
107
512
2.23
12.37
6.2
3.9
mmol/l
0.8
2.0
3.04
86
378
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
50
164
3.17
12.29
2.6
1.3
mg/l
497.9
512.8
0.09
50
156
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
67
261
2.69
12.10
1.7
3.0
g/l
0.3
1.4
2.41
61
231
(40765089) Chromosome analysis panel - Blood by G-banded
14
15
9.46
11.68
1.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
15
5
30.45
11.67
1.7
6.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
21
37
5.78
11.51
10.2
3.6
u/l
227.4
208.1
0.34
21
37
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
63
245
2.69
11.42
1.6
2.7
g/l
37.5
37.5
0.04
58
209
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
672
5648
1.70
11.32
32.3
7.6
u/l
83.3
79.6
1.26
658
5277
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
45
5.22
11.30
2.5
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
108
539
2.14
11.22
6.3
3.9
ph
7.4
7.4
0.11
13
61
(3017732) Neutrophils [#/volume] in Blood
98
472
2.20
11.13
3.3
3.1
e9/l
5.3
4.1
0.36
76
360
(3019832) Treponema pallidum Ab [Presence] in Serum
92
433
2.25
11.05
1.5
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
25
6.91
11.04
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
46
5.10
11.04
2.5
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
19
8.01
11.03
2.2
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
108
546
2.11
10.85
6.4
3.9
kpa
5.1
5.2
0.48
102
506
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
129
705
1.96
10.46
2.8
2.4
g/l
0.2
0.2
0.39
116
657
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
65
269
2.52
10.41
3.4
2.7
u/ml
0.3
0.4
0.29
37
150
(3015377) Calcium [Moles/volume] in Serum or Plasma
351
2554
1.60
10.39
5.6
3.5
mmol/l
2.3
2.3
6.09
322
2213
(3019225) pH of Specimen
134
744
1.94
10.37
12.4
4.4
—
—
—
0
0
(4212803)
14
6
23.66
10.26
1.1
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
10
11.12
10.18
3.8
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
10
11.12
10.18
3.8
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
10
11.12
10.18
3.8
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
85
402
2.23
10.09
7.1
4.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
26
63
4.22
9.94
3.8
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
55
4.45
9.84
2.5
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
51
4.60
9.81
3.3
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
22
47
4.77
9.80
1.3
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46
166
2.86
9.62
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46
166
2.86
9.62
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
93
3.53
9.54
1.1
1.0
—
—
—
0
0
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
9
0
+∞
9.39
5.3
0.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
30
5.75
9.30
1.8
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
80
383
2.19
9.22
1.5
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
222
1486
1.65
9.01
5.0
4.0
ng/l
86.0
313.2
3.30
188
1215
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
626
7095
0.63
9.00
5.2
5.1
mmol/l
2.5
2.7
4.06
591
6431
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
12
9.27
8.99
3.8
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1880
1.60
8.99
1.9
1.6
nmol/l
19.3
20.4
0.63
250
1583
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
407
3151
1.52
8.73
2.3
2.0
pmol/l
90.0
94.5
1.14
288
1637
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
53
221
2.48
8.38
1.5
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
119
3.02
8.15
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
324
2419
1.52
8.09
3.7
3.2
ng/l
1490.7
1681.4
0.27
301
2084
(3000963) Hemoglobin [Mass/volume] in Blood
717
7841
0.62
8.07
74.2
23.0
g/l
116.4
134.9
89.90
706
7694
(3010813) Leukocytes [#/volume] in Blood
717
7840
0.62
8.04
73.9
22.9
e9/l
8.5
6.8
0.95
700
7595
(3026361) Erythrocytes [#/volume] in Blood
717
7839
0.62
8.01
73.8
22.9
e12/l
3.9
4.5
78.62
700
7594
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
14
7.94
8.00
3.8
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
717
7838
0.62
7.99
73.5
22.8
pg
31.0
30.4
13.67
708
7695
(3007461) Platelets [#/volume] in Blood
717
7837
0.62
7.96
73.9
22.9
e9/l
191.1
244.4
35.36
702
7618
(3024731) MCV [Entitic volume]
717
7836
0.62
7.94
73.6
22.8
fl
93.5
91.3
20.41
708
7695
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
21
6.26
7.73
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
308
2302
1.51
7.54
4.0
3.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
165
2.62
7.52
2.5
1.4
u/l
12.8
8.2
0.77
37
132
(3002582) Erythrocytes [#/volume] in Urine
311
2336
1.50
7.41
4.6
3.4
e6/l
41.1
95.0
1.10
251
1844
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
121
2.88
7.33
1.2
1.2
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
7
0
+∞
7.30
3.0
0.0
ng/l
8.2
—
—
7
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
306
2305
1.49
7.13
3.9
2.1
u/l
158.1
256.7
1.72
295
2158
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
613
6883
0.67
7.04
4.9
4.5
mmol/l
1.3
1.4
15.70
575
6241
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
72
370
2.03
6.93
7.2
3.9
mmol/l
24.7
24.2
0.44
65
336
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
59
3.62
6.62
1.3
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
121
746
1.72
6.58
4.9
3.9
mmol/l
2.1
2.2
0.06
97
591
(3019420) Tryptase [Mass/volume] in Serum or Plasma
15
33
4.60
6.47
3.5
1.2
ug/l
16.0
6.2
0.84
15
28
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
5
18.16
6.27
4.4
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
0
+∞
6.25
1.2
0.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
67
3.34
6.17
1.4
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
41
176
2.39
6.15
1.9
2.1
g/l
122.1
128.2
0.61
30
130
(3008152) Bicarbonate [Moles/volume] in Arterial blood
92
535
1.80
6.13
9.8
7.3
mmol/l
24.5
24.4
0.07
87
503
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
113
700
1.70
6.04
3.8
3.0
ng/l
220.4
236.7
0.22
106
644
(3031040) Bacteria [#/volume] in Urine by Automated count
557
4787
1.41
6.00
5.8
4.7
e6/l
163.9
2631.9
1.71
15
94
(1616796) Gas panel - Central venous blood
39
166
2.41
5.96
3.8
3.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
673
7356
0.68
5.79
39.7
14.9
—
—
—
0
0
(4062490)
20
60
3.39
5.74
1.5
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
139
922
1.60
5.68
10.1
7.8
kpa
4.9
5.1
1.55
132
879
(3027801) Oxygen [Partial pressure] in Arterial blood
139
923
1.60
5.65
10.1
7.8
kpa
11.6
11.9
0.47
131
882
(3042631) Mycobacterium sp identified in Specimen
29
110
2.69
5.61
2.9
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
628
6932
0.71
5.50
5.2
4.6
mmol/l
4.3
4.6
8.10
598
6329
(3037522) Nuclear Ab [Titer] in Serum
133
883
1.59
5.41
1.3
1.3
titre
504.8
458.4
0.14
29
194
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
174
2.30
5.39
2.4
1.4
iu/l
19.3
24.7
0.61
32
146
(3003396) Base excess in Arterial blood by calculation
138
925
1.58
5.39
10.7
7.8
mmol/l
1.5
1.3
0.19
103
718
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
176
1246
1.51
5.37
4.5
3.1
e6/l
2.5
2.1
0.22
100
719
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
58
3.32
5.32
1.5
1.3
g/l
5.6
7.5
0.95
13
40
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
58
3.32
5.32
1.5
1.3
g/l
0.3
0.4
0.40
12
39
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
58
3.32
5.32
1.5
1.3
g/l
2.5
2.8
0.13
14
40
(3016502) Oxygen saturation in Arterial blood
127
838
1.60
5.30
11.1
8.1
%
95.7
95.4
0.15
120
805
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
591
6574
0.72
5.25
6.0
6.1
mmol/mol
39.8
40.4
0.80
552
6029
(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
5
0
+∞
5.21
12.4
0.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
273
2116
1.41
5.17
4.6
3.3
e6/l
0.4
0.5
0.35
215
1622
(3018095) Leukocytes [#/volume] in Urine
329
2636
1.39
5.12
5.4
3.9
e6/l
49.2
116.2
1.45
260
1950
(3009445) Proteinase 3 Ab [Units/volume] in Serum
60
323
1.92
5.11
1.2
1.5
—
11.8
—
0
8
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
40
3.80
5.10
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
27
4.49
5.04
1.2
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
23
4.83
5.02
1.2
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
261
2018
1.41
4.99
4.7
3.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
22
77
2.90
4.95
1.6
2.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
112
2.55
4.91
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
78
2.87
4.84
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
92
573
1.67
4.83
6.9
5.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
205
2.10
4.70
1.4
1.6
iu/ml
0.2
31.7
—
8
38
(3023199) Leukocytes [#/volume] in Pleural fluid
26
103
2.57
4.66
1.6
1.3
e6/l
2168.9
1565.2
0.46
20
67
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
53
3.25
4.63
1.4
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
93
2.62
4.50
1.6
1.3
e6/l
83687.4
26420.7
0.37
14
49
(3052851) Hemolysis interference index of Serum or Plasma
43
218
2.02
4.37
4.5
3.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
35
3.75
4.37
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
35
3.75
4.37
1.2
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
26
4.27
4.36
9.3
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
66
2.92
4.35
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
629
6865
0.74
4.33
6.0
4.8
mmol/l
6.1
6.0
0.86
583
6165
(3013707) Erythrocyte sedimentation rate by Westergren method
599
5359
1.34
4.18
5.9
4.1
mm/h
19.4
12.9
11.06
564
4901
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
14
42
3.37
4.05
1.4
1.0
mg/l
27.1
45.2
1.08
14
33
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
14
6.48
3.99
1.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
38
3.46
3.91
1.3
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
354
2963
1.32
3.88
3.8
3.9
ng/l
63.1
53.1
0.10
277
2171
(3000991) Gas panel - Venous blood
95
631
1.56
3.87
12.8
8.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
101
2.41
3.84
2.2
1.6
g/l
0.9
0.8
0.12
19
77
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
34
3.56
3.77
3.8
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
705
7524
0.73
3.77
37.7
10.7
u/l
27.5
26.2
1.37
685
7221
(3012441) Differential panel - Pleural fluid
23
96
2.43
3.75
1.3
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
16
5.67
3.66
1.9
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
11
30
3.70
3.64
2.4
1.3
mg/l
57.3
73.0
0.37
11
23
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
40
3.28
3.63
1.3
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
46
256
1.84
3.61
8.5
7.8
mmol/l
1.3
1.3
0.04
41
224
(3000850) Epithelial cells [#/volume] in Urine
209
1635
1.36
3.60
3.4
2.7
e6/l
5.1
5.1
0.02
191
1439
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
172
1304
1.39
3.59
4.2
2.9
e6/l
1.7
1.1
0.77
101
770
(40761535) Cells panel - Urine sediment
94
636
1.53
3.54
3.1
3.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
41
3.20
3.50
1.3
1.0
mg/l
236.2
238.8
0.02
13
35
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
59
358
1.69
3.47
3.2
3.3
pmol/l
4.5
4.5
0.03
52
310
(3014111) Lactate [Moles/volume] in Serum or Plasma
98
676
1.50
3.38
9.8
7.2
mmol/l
1.4
1.4
0.33
93
644
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
10
7.04
3.37
2.1
4.9
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
37
3.27
3.35
1.3
1.6
ug/l
2.8
3.5
—
7
29
(3012501) Base excess in Blood by calculation
34
176
1.97
3.32
4.6
4.6
mmol/l
2.6
2.8
0.10
22
122
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
219
1.86
3.32
1.4
1.5
ug/g
245.4
289.0
0.68
24
125
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
7
8.62
3.26
1.3
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
6
7
8.62
3.26
1.3
1.0
mg/g
8.4
6.8
—
6
7
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
11
6.40
3.19
3.1
3.3
—
—
—
0
0
(4027681)
11
35
3.17
2.93
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
46
2.85
2.92
1.6
1.5
u/l
3.5
11.8
—
8
24
(3036048) Francisella tularensis Ab [Titer] in Serum
7
13
5.42
2.87
1.1
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
9
6.70
2.87
1.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
9
6.70
2.87
1.0
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
194
1552
1.32
2.83
4.0
2.9
mosm/kgh2o
546.4
561.0
0.42
180
1323
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
49
300
1.67
2.83
1.8
2.0
u/l
35.6
39.2
0.62
42
263
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
63
411
1.57
2.83
16.5
11.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
18
4.47
2.80
1.9
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
188
2318
0.76
2.79
3.5
3.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
84
2.29
2.78
4.4
4.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
186
2296
0.76
2.78
3.8
4.5
%
21.5
21.3
0.05
89
1139
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
622
6675
0.79
2.77
41.0
14.6
ml/min/173m2
77.0
78.3
0.64
544
5516
(3003338) MCHC [Mass/volume]
535
5837
0.80
2.76
64.0
20.5
g/l
332.2
332.3
0.14
530
5786
(3052592) Norovirus Ag [Presence] in Stool
7
14
5.03
2.73
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
29
153
1.92
2.73
2.7
2.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
16
66
2.45
2.72
1.3
1.2
u/l
10.8
14.1
0.42
16
60
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
95
682
1.44
2.71
2.7
2.4
u/l
29.3
105.8
0.55
83
575
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
10
6.03
2.70
3.3
3.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
37
3.00
2.70
2.1
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
183
1.83
2.68
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
620
6642
0.80
2.63
5.4
4.1
mmol/l
1.5
1.3
3.99
587
5992
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
55
2.57
2.62
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
20
4.03
2.57
4.5
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
128
1644
0.74
2.52
2.8
3.1
ug/l
0.7
0.8
0.43
80
1109
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
75
2.29
2.52
1.3
2.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
201
1648
1.28
2.43
1.6
1.8
pmol/l
74699250.6
7979545.4
0.43
166
1341
(3020876) Protein [Mass/time] in 24 hour Urine
16
70
2.31
2.42
1.6
2.1
—
1.7
—
0
5
(40767503) Oxygen content in Capillary blood by calculation
29
160
1.84
2.42
2.7
2.5
%
15.7
15.9
0.07
20
80
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
500
0.57
2.41
1.9
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
40
2.77
2.38
1.1
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
247
0.40
2.33
2.7
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
86
2.11
2.24
1.5
1.8
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
56
378
1.51
2.21
4.4
4.1
%
46.7
47.3
0.06
56
372
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
219
1.67
2.18
1.2
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
14
4.31
2.15
1.8
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
221
1.65
2.12
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
102
1.98
2.11
1.4
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
332
2919
1.21
2.11
2.8
2.3
nmol/l
75.1
77.8
1.02
309
2555
(3051651) Icteric interference index of Serum or Plasma
12
49
2.47
2.11
8.5
3.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
82
2.09
2.07
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
513
0.61
2.04
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
224
1.63
2.02
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
321
1.52
2.00
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
156
1893
0.79
1.98
2.3
1.6
mmol/l
1.9
1.4
2.38
141
1566
(3020891) Body temperature
47
314
1.52
1.97
6.8
4.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
43
282
1.55
1.96
2.8
2.1
ug/l
151.3
459.7
1.17
38
265
(3035880) pH of Pleural fluid
12
51
2.37
1.95
1.5
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
67
482
1.42
1.95
14.9
9.2
%
1.5
1.4
0.40
67
477
(3035320) C reactive protein [Mass/volume] in Body fluid
0
51
0.00
1.89
0.0
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
538
4981
1.19
1.88
6.0
4.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
13
59
2.22
1.84
1.1
1.2
nmol/l
394.6
372.8
—
8
52
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
40
2.52
1.84
1.9
1.5
u/field
1.8
3.3
—
5
29
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
153
1.72
1.81
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
696
0.69
1.80
1.7
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
30
185
1.64
1.77
1.5
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
708
7388
0.82
1.75
55.5
18.7
mmol/l
4.0
4.0
0.49
696
7173
(3001893) Eosinophils/100 leukocytes in Pleural fluid
8
30
2.68
1.72
2.0
1.3
%
1.4
3.6
—
8
23
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
31
2.59
1.66
1.1
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
77
585
1.35
1.65
4.1
4.1
ng/l
83.7
90.2
0.36
72
514
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
608
6419
0.84
1.63
5.2
4.6
mu/l
2.0
2.1
0.36
570
5775
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
692
1.32
1.63
2.2
2.6
ug/l
4.2
6.8
1.63
78
605
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(4268621)
13
63
2.08
1.60
2.2
2.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
16
85
1.90
1.55
1.6
1.4
mmol/l
6.3
6.5
0.17
16
80
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
333
0.59
1.54
1.5
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
10
44
2.29
1.53
1.4
2.2
mmol/l
9.8
9.5
—
10
38
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
15
3.35
1.52
1.4
2.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
709
7373
0.83
1.52
50.3
18.5
mmol/l
139.2
139.6
4.76
696
7164
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
21
2.87
1.50
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
255
2870
0.85
1.49
4.2
5.2
ug/l
4.1
3.0
0.21
232
2535
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
16
3.14
1.44
1.6
3.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
16
3.14
1.44
1.0
1.0
umol/l
2.4
4.8
—
5
16
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
16
3.14
1.44
3.2
6.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
22
2.74
1.43
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
22
2.74
1.43
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
187
1612
1.20
1.42
3.7
3.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
88
1.83
1.42
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
29
2.42
1.39
1.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
31
207
1.51
1.37
1.1
1.2
—
487.1
—
0
7
(3045788) Cell count panel - Pleural fluid
15
82
1.84
1.36
1.7
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
82
1.84
1.36
1.8
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
603
6331
0.86
1.34
48.7
16.8
%
35.4
39.6
18.71
383
4306
(3027273) Bicarbonate [Moles/volume] in Venous blood
54
404
1.36
1.31
3.3
3.7
mmol/l
24.6
25.3
0.74
54
391
(40768804) Tissue Pathology biopsy report
307
2777
1.16
1.30
2.6
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
123
1459
0.82
1.27
1.2
1.2
u/ml
2.3
1.6
0.21
31
387
(3004451) EKG impression Narrative
9
45
2.01
1.23
1.3
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
33
229
1.46
1.23
1.5
1.5
g/l
1.2
1.2
0.16
33
217
(36660697) Celiac disease serology panel - Serum
36
499
0.71
1.22
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
93
1.73
1.21
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
145
0.48
1.20
2.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
15
249
0.60
1.19
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
26
2.32
1.19
2.5
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
125
1.61
1.18
3.3
3.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
157
1.54
1.18
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
33
0.00
1.16
0.0
2.4
—
588.5
—
0
27
(3013512) EKG study
252
2265
1.15
1.16
5.0
4.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
35
0.00
1.15
0.0
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
7.4
2.1
ng/l
81.4
118.4
—
5
14
(3023419) Bacteria identified in Sputum by Culture
17
104
1.65
1.10
2.1
2.9
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
66
1.83
1.09
1.8
2.1
u/field
1.0
2.2
—
5
27
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
379
3516
1.13
1.08
4.0
3.9
estimate
0.0
0.0
0.00
71
640
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
89
1.70
1.08
1.3
1.2
u/ml
4.4
6.5
—
5
39
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
111
937
1.21
1.08
3.5
4.6
%
28.4
31.8
2.80
89
611
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
97
1.66
1.07
1.0
1.1
—
14.6
—
0
6
(3035350) Ketones [Presence] in Urine by Test strip
373
3461
1.13
1.06
4.0
3.9
estimate
0.0
0.0
0.00
77
655
(3008898) HLA-B27 [Presence]
13
215
0.60
1.04
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
211
2348
0.87
1.03
3.1
3.2
mmol/l
7.7
7.5
0.20
186
1933
(3048689) Calprotectin [Mass/mass] in Stool
95
794
1.22
1.02
1.9
2.2
ug/g
154.8
133.7
0.21
70
620
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
14
83
1.70
1.01
1.0
1.1
%
123.0
116.0
0.29
14
77
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
166
1461
1.17
1.01
3.7
3.1
mmol/l
2.4
2.5
0.09
155
1289
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
172
1.47
1.00
3.0
4.0
mg/l
38.5
26.7
1.11
18
115
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
51
397
1.30
1.00
16.1
10.2
mmol/l
24.3
24.7
0.33
46
371
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
503
0.74
1.00
1.8
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
212
2352
0.87
0.99
4.0
4.0
mg/mmol
13.5
9.8
0.45
141
1467
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
49
1.84
0.98
1.0
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
48
372
1.31
0.97
2.6
2.5
%
0.7
0.7
0.39
48
361
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
30
0.00
0.97
0.0
2.2
—
3717.1
—
0
18
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
36
1.95
0.97
1.4
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
54
1.86
0.97
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
69
1.75
0.96
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
555
0.76
0.95
1.9
2.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
37
1.90
0.94
1.0
1.2
nmol/l
114.9
136.0
—
7
37
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
109
1.57
0.94
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
372
3472
1.12
0.93
5.4
5.3
estimate
0.0
0.0
0.50
76
653
(40768443) Skin Pathology biopsy report
42
322
1.32
0.93
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
52
1.74
0.92
4.6
2.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
134
1.50
0.92
1.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
171
0.58
0.92
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
425
4004
1.11
0.89
3.4
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
29
2.08
0.89
2.3
4.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
180
1.40
0.82
2.5
3.4
nmol/l
0.8
0.9
0.42
16
146
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
116
1011
1.17
0.82
1.5
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
89
1.58
0.81
3.2
1.1
—
—
—
0
0
(4010399)
41
518
0.78
0.80
1.6
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
24
0.00
0.79
0.0
1.1
—
324.8
—
0
16
(3033799) Differential panel - Peritoneal fluid
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
48
1.67
0.79
1.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
26
0.00
0.78
0.0
2.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
90
1.56
0.78
3.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
73
614
1.21
0.78
4.6
4.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
27
0.00
0.77
0.0
1.2
—
8.9
—
0
27
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
34
1.77
0.76
1.8
1.1
u/l
231.7
564.3
—
6
29
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.6
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
28
0.00
0.76
0.0
1.4
—
16.2
—
0
18
(3037556) Urate [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
396
1.25
0.76
2.6
2.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
75
1.61
0.75
8.8
3.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
105
918
1.16
0.73
11.8
7.7
—
—
—
0
0
(3044889) 12 lead EKG panel
491
5122
0.91
0.72
6.1
4.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
104
912
1.16
0.70
1.5
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
209
1919
1.12
0.69
4.3
4.1
estimate
0.0
0.0
0.80
71
635
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
169
0.65
0.69
1.6
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
85
1.54
0.69
1.0
1.1
—
—
—
0
0
(4306422)
13
86
1.52
0.66
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
201
0.69
0.65
1.5
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
205
2218
0.90
0.64
3.3
3.2
mg/l
2870.4
275.2
2.49
151
1410
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
489
1.20
0.63
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
79
1.53
0.62
1.2
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
208
1.31
0.62
1.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
63
1.59
0.62
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
20
0.00
0.60
0.0
1.3
—
116.7
—
0
15
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
474
4553
1.08
0.59
4.2
3.2
u/l
69.9
51.6
2.49
444
4207
(3022217) INR in Platelet poor plasma by Coagulation assay
120
1079
1.13
0.58
21.4
27.0
inr
1.2
1.3
0.34
23
148
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
73
1.51
0.56
1.2
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
73
1.51
0.56
1.0
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
88
0.57
0.56
1.0
1.0
—
2.4
—
0
31
(4034850)
16
216
0.74
0.54
8.6
11.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
93
830
1.13
0.52
3.5
4.0
ug/l
15.4
26.3
0.32
76
697
(3028300) Cannabinoids [Presence] in Urine
16
214
0.74
0.51
1.4
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
325
0.79
0.51
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
213
0.75
0.50
1.4
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
171
1.29
0.50
1.5
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
45
1.56
0.49
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
68
1.48
0.47
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
120
1.34
0.46
2.7
2.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
51
1.38
0.44
1.9
3.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
139
1.30
0.44
2.6
1.9
pmol/l
175.5
226.3
2.11
18
129
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
31
1.62
0.43
3.6
1.7
ug/l
33.4
54.4
—
5
31
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
31
1.62
0.43
1.0
1.1
iu/ml
106.4
163.6
—
5
31
(3005322) IgE [Units/volume] in Serum or Plasma
43
369
1.17
0.42
1.7
1.2
u/ml
508.3
264.7
0.42
35
333
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
56
1.43
0.42
1.3
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.8
2.0
umol/l
74.2
47.5
—
5
24
(3021788) Differential panel - Synovial fluid
18
140
1.29
0.42
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
167
1.26
0.42
2.1
2.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
150
0.73
0.41
1.7
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
16
0.00
0.41
0.0
1.9
—
2.9
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
86
780
1.11
0.40
1.3
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
8.4
6.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
35
299
1.18
0.37
3.5
3.3
u/ml
55.3
62.0
0.08
35
285
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
147
0.75
0.37
2.3
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
66
592
1.12
0.37
4.0
2.8
ml/min/173m2
65.3
64.0
0.09
34
256
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
71
1.27
0.36
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
212
0.80
0.36
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
212
0.80
0.36
1.4
2.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
90
1.34
0.36
1.4
1.3
nmol/l
0.5
0.6
1.17
12
82
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
46
1.31
0.33
2.3
2.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
200
1904
1.06
0.32
3.7
3.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
85
788
1.09
0.28
6.3
3.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
63
1.27
0.28
1.8
3.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
63
1.27
0.28
1.0
1.1
%
72.9
95.7
—
8
58
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17
140
1.22
0.27
1.1
1.2
—
29.1
—
0
12
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
281
2715
1.05
0.27
4.1
4.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
141
1.21
0.26
1.2
1.2
—
8.8
—
0
12
(3049717) Cytology report of Urine Cyto stain
31
351
0.88
0.25
2.9
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
114
1075
1.07
0.25
1.2
1.3
u/ml
1.6
12.0
5.38
39
392
(4094501)
14
170
0.82
0.25
1.0
1.1
—
—
—
0
0
(4146454)
6
84
0.71
0.24
5.0
2.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
84
0.71
0.24
2.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
39
1.28
0.23
1.2
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
40
1.25
0.22
17.8
12.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
118
1120
1.06
0.22
1.2
1.3
iu/ml
25.4
35.8
0.67
41
343
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
4.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
102
0.78
0.21
1.4
2.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
105
0.76
0.21
1.1
1.1
g/l
1.5
1.5
—
8
94
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.1
—
16.7
—
0
13
(3014051) Protein [Presence] in Urine by Test strip
14
166
0.84
0.20
2.6
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
80
1.25
0.20
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
498
0.92
0.19
2.7
3.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
166
1600
1.05
0.19
4.1
4.3
kg/l
1.0
1.0
1.83
25
233
(3037121) Protein [Mass/volume] in Urine
31
280
1.11
0.18
2.5
3.2
g/l
0.7
0.3
0.81
17
114
(3025130) Human papilloma virus identified in Specimen
7
58
1.21
0.18
2.7
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
796
1.06
0.18
1.6
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
60
1.17
0.18
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
103
983
1.05
0.17
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
25
224
1.12
0.17
4.3
5.2
—
—
—
0
0
(3000492) Spirometry study
67
631
1.07
0.17
1.9
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
67
0.74
0.17
1.2
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
120
1.17
0.16
1.2
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
149
1.14
0.15
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
77
0.78
0.15
2.7
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
307
0.91
0.15
2.3
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
82
1.10
0.15
1.3
1.3
nmol/l
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
217
1.11
0.14
1.6
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
88
0.79
0.14
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
84
1.19
0.14
1.5
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
151
1.13
0.13
1.4
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
190
1.11
0.13
1.2
1.2
—
18.1
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
252
0.91
0.13
2.0
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
229
1.09
0.12
1.5
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
21
191
1.10
0.12
2.9
1.8
nmol/l
44.4
41.3
0.15
21
181
(3011288) Drugs identified in Urine by Screen method
12
136
0.88
0.11
2.9
2.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
46
1.09
0.09
1.8
2.2
%
13.8
13.1
—
5
46
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
204
1.08
0.08
1.8
2.0
—
—
—
0
0
(4281824)
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
225
1.07
0.07
1.8
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
709
7121
0.98
0.07
55.1
15.7
mg/l
26.6
25.6
0.33
656
5721
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
153
0.91
0.07
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
437
0.96
0.06
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
208
1.06
0.05
2.6
2.5
ug/min
407.3
100.2
0.42
12
130
(3000330) Specific gravity of Urine by Test strip
38
394
0.96
0.05
3.8
4.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
19
179
1.06
0.05
1.2
1.2
—
2.8
—
0
19
(3000475) Leukocytes [#/volume] in Synovial fluid
18
190
0.95
0.04
1.5
1.6
e6/l
14074.7
17354.7
0.19
11
137
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
19
181
1.05
0.03
1.2
1.2
—
7.0
—
0
25
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
401
1.02
0.02
1.1
1.2
iu/ml
47.3
117.9
2.05
14
151
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
527
5283
0.99
0.02
4.2
3.8
pmol/l
14.9
14.9
0.02
491
4715
(3045424) Erythrocytes [Presence] in Urine
11
117
0.94
0.01
2.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
136
0.96
0.00
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
123
0.98
0.00
1.2
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
779
1.00
0.00
1.6
1.8
%
1.6
1.5
0.27
66
676
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
59
1.02
0.00
2.2
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
6
62
0.97
0.00
1.0
1.5
—
38.2
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
11.4
—
0
5
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
61
0.98
0.00
1.2
1.0
mg/l
326.2
285.5
—
6
53
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.8
—
75.2
—
0
9
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
61
0.98
0.00
1.0
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
58
0.86
0.00
1.4
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
60
1.00
0.00
1.0
1.8
%
9.0
10.7
—
6
60
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.9
—
0
6
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.9
—
0
9
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
2.4
—
122.8
—
0
5
(3007916) DNA double strand Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MYELOID_LEUKAEMIA – Myeloid leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).